Cite Filings / RVMD / 0000102909-26-002203
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

Revolution Medicines, Inc. · Filed 2026-03-27 · Acc 0000102909-26-002203

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-03-27 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-03-26 144 Sale of Securities
  • 2026-03-26 4 Mancini Anthony sold 37,450 shares at an average $95.56 ($3,578,821)
  • 2026-03-26 3 Initial Statement of Ownership
  • 2026-03-26 3 Initial Statement of Ownership
  • 2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · JANUS HENDERSON GROUP Ltd. 3.5%
  2. 2026-11-16 SCHEDULE 13G/A · Baker Bros. Advisors LP 4.92%
  3. 2024-02-13 SC 13G/A · BB Biotech AG 3.1%
  4. 2023-02-14 SC 13G/A · BB Biotech AG 5.4%
  5. 2022-09-30 SC 13G · BB B iotech AG 5.2%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…